Hemangio Journal

A pilot study of the oral drug OXC-101 was presented at the American Association for Cancer Research (AACR) Annual Meeting in April. The research was conducted in nine pet dogs with either lymphoma or hemangiosarcoma. OXC-101 works through two mechanisms: it forces cancer cells to incorporate damaged DNA building blocks, and it disrupts microtubules needed […]

Canine hemangiosarcoma cells take up boron through LAT1, making them vulnerable to neutron irradiation.

Organoids and xenografts reveal PLAAT3 as a key driver of invasion

Liver involvement remains the strongest negative prognostic indicator, but pulmonary and muscular metastases showed no significant impact on survival.

Hemangiosarcoma cells use lactate to activate genes that let them synthesize asparagine from glutamine.

This study provides the first controlled evidence that trained dogs can detect a distinct odor signature in the blood serum of dogs with hemangiosarcoma

A Recap of The Various Studies Being Conducted in the Fight Against the Diagnosis

The Study Reveals Differences According On Age and Sex.

Researchers at the University of Minnesota's College of Veterinary Medicine Have Discovered an Epigenetic Mark that Drives Tumor Growth

The Morris Animal Foundation is supporting a study to find genetic markers that may increase a dog's susceptibility to the condition. As...

According to the Norwegian University of Life Sciences, macrophages can potentially be manipulated to inhibit cancer spread.

In part two, Dr. Breitschwerdt connects all the dots about cancer and infections